Literature DB >> 19892471

Axial length: an underestimated endophenotype of myopia.

Weihua Meng1, Jacqueline Butterworth, Francois Malecaze, Patrick Calvas.   

Abstract

Myopia is a major threat for vision health across the world. Around 1 in 4 in the West and over 3 in 4 in the East are suffering from this common eye disorder. It is a complex trait affected by both genetic and environmental determinants. Axial length is an essential man-made parameter generated from ocular biometric components. It represents a combination of anterior chamber depth, lens thickness and vitreous chamber depth. Meanwhile, it is an endophenotype of the phenotype of myopia. In the mainstream genetic studies on vision science, it is always treated only as a parameter rather than an endophenotype. However, in this article, the potential advantages are discussed for axial length analysed as an endophenotype independently. It may provide solutions for the exploration of myopia genetics.

Entities:  

Mesh:

Year:  2009        PMID: 19892471     DOI: 10.1016/j.mehy.2009.09.025

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Relationships between central and peripheral corneal thickness in different degrees of myopia.

Authors:  Sara Ortiz; Laura Mena; Ana Rio-San Cristobal; Raul Martin
Journal:  J Optom       Date:  2013-05-16

2.  Body stature growth trajectories during childhood and the development of myopia.

Authors:  Kate Northstone; Jeremy A Guggenheim; Laura D Howe; Kate Tilling; Lavinia Paternoster; John P Kemp; George McMahon; Cathy Williams
Journal:  Ophthalmology       Date:  2013-02-14       Impact factor: 12.079

3.  Coordinated genetic scaling of the human eye: shared determination of axial eye length and corneal curvature.

Authors:  Jeremy A Guggenheim; Xin Zhou; David M Evans; Nicholas J Timpson; George McMahon; John P Kemp; Beate St Pourcain; Kate Northstone; Susan M Ring; Qiao Fan; Tien-Yin Wong; Ching Yu Cheng; Chiea Chuen Khor; Tin Aung; Seang Mei Saw; Cathy Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-07       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.